MORPHOLOGICAL AND IMMUNOHISTOCHEMICAL CHARACTERISTICS OF THE THYMUS DURING CHEMICAL CARCINOGENESIS INDUCED BY 1,2-DIMETHYLHYDRAZINE ADMINISTRATION



Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

The aim of the study was to examine the histological and immunohistochemical characteristics of the thymus 5 months after the intraperitoneal administration of the carcinogen (1,2-dimethylhydrazine in the dose of 20 mg/kg once a week for 2 weeks). The study was conducted on 50 outbred albino male rats. Paraffin sections of the thymus were stained with hematoxylin-eosin and were processed by an immunohistochemical method using antibodies against CD3, CD30, CD68, synaptophysin, S-100 protein, p53, bcl-2, Ki-67, as well as against IgM and IgG. It was found that carcinogen administration resulted in the increased number of thymic cells expressing bcl-2, S-100 and Ki-67, active T-lymphocytes and thymopoietic microenvironment cells, as well as in the change of the correlation between medullary and cortical CD3 +-thymocytes with a predominance of the latter. Thus, the malignant tumor, developing in the colon, on the one hand, inhibits the supply of the precursors of thymopoiesis to the thymus, while on the other - enhances the proliferation and differentiation of thymocytes into mature forms

Full Text

Restricted Access

About the authors

G. Yu. Struchko

I. N. Ulyanov Chuvash State University

Email: glebstr@mail.ru

L. M. Merkulova

I. N. Ulyanov Chuvash State University

Ye. V. Moskvichyov

I. N. Ulyanov Chuvash State University

References

  1. Барышников А. Ю. Взаимодействие опухоли и иммунной системы. Практ. онкол., 2003, т. 4, № 3, с. 127-130.
  2. Кострова О. Ю., Михайлова М. Н., Стручко Г. Ю. и др. Акцидентальная инволюция тимуса крыс на фоне развития аденокарциномы толстой кишки, индуцируемой 1,2-диметилгидразином на фоне удаления селезенки. Вестн. Чувашск. ун-та, 2012, № 3, с. 416-423.
  3. Кумар Г. Л. и Рудбек Л. Иммуногистохимические методы: руководство. М., изд. ЗАО Амтео, 2011.
  4. Москвичев Е. В., Меркулова Л. М. и Стручко Г. Ю. Иммуногистохимическая характеристика апоптоза и клеточной пролиферации в тимусе при экспериментальной опухоли толстой кишки. Иммунология, 2012, т. 33, № 6, с. 303-305.
  5. Brtnicky T., Podrazil M., Bartunkova J. et al. Active cellular immu notherapy of ovarian cancer using dendritic cells. Ceska Gynekol., 2012, v. 77, № 3, p. 215-220.
  6. Buss N. A., Henderson S. J., McFarlane M. et al. Monoclonal antibody therapeutics: history and future. Curr. Opin. Pharmacol., 2012, v. 12, № 5, p. 615-622.
  7. De Souza A. P. and Bonorino C. The immune system: endogenous anticancer mechanism. Front. Biosci., 2012, v. 1, № 4, p. 2354-2364.
  8. Flores K. G., Li J., Sempowski G. D. et al. Analysis of the human thy mic perivascular space during aging. J. Clin. Invest., 1999, v. 104, № 8, p. 1031-1039.
  9. Ghiringhelli F., Puig P. E., Roux S. et al. Tumor cells convert imma ture myeloid dendritic cells into TGF-ß-secreting cells inducing CD4+CD25+ regulatory T cell proliferation. J. Exp. Med., 2005, v. 202, p. 919-929.
  10. Gress R. E. and Deeks S. G. Reduced thymus activity and infection prematurely age the immune system. J. Clin. Invest., 2009, v. 119, № 10, p. 2884-2887.
  11. Israels L. G. and Israels E. D. Apoptosis. The Oncologist, 1999, v. 4, № 4, p. 332-339.
  12. Jacoby R. F., Lior X., Teng B. B. et al. Mutations in the K-ras oncogene induced by 1,2-dimethylhydrazine in preneoplastic and neoplastic rat colonic mucosa. J. Clin. Invest., 1991, v. 87, № 2, p. 624-630
  13. Nishimura T., Nakui M., Sato M. et al. The critical role of Th1dominant immunity in tumor immunology. Cancer Chemother. Pharmacol., 2000, v. 46, p. 52-61.
  14. Reed J. C., Tsujimoto Y., Alpers J. D. et al. Regulation of bcl-2 proto-oncogene expression during normal human lymphocyte proli feration. Science, 1987, v. 236, p. 1295-1299.
  15. Sempowski G. D., Rhein, M. E., Scearce, R. M. and Haynes B. F. Leukemia inhibitory factor is a mediator of Escherichia coli lipopolysaccharide-induced acute thymic atrophy. Eur. J. Immunol., 2002, v. 32, p. 3066-3070.
  16. Whiteside T. L. Immune responses to malignancies. J. Allergy Clin. Immunol., 2010, v. 125, p. 272-283.

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2014 Eco-Vector



СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: № 0110212 от 08.02.1993.

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies